출판 : MarketsandMarkets (마켓츠앤마켓츠) 출판년월 : 2022년08월
부비강 확장기(Sinus Dilation Devices) 시장 : 제품 (풍선 확장 장치, 내시경 (사이노스코프, 시노스코프), 휴대용), 치료 (독립형, 하이브리드), 환자 유형 (성인, 소아), 환자 관리 환경 (병원 및 ASC, 이비인후과 진료소) – 2027 년까지의 세계 예측
Sinus Dilation Devices Market by Product (Balloon Dilation Devices, Endoscope (Rhinoscope, Sinoscope), Handheld), Procedure (Standalone, Hybrid), Patient Type (Adult, Pediatric) & Patient Care Setting (Hospitals & ASC, ENT Office) – Global Forecast to 2027
| 페이지수 | 169 |
| 도표수 | 162 |
| 구성 | 영문조사보고서 |
| 가격 |
The global sinus dilation devices market is anticipated to reach USD 3.8 Billion by 2027 from USD 2.8 billion in 2022, at a CAGR of 6.6% during the forecast period. The growth of the market is primarily driven by the factors such as growing extensiveness of chronic sinusitis and rising inclination of minimally invasive surgeries such as balloon sinuplasty.
세계 부비강 확장기 시장은 예측 기간 동안 6.6%의 CAGR로 2022년 28억 달러에서 2027년 38억 달러에 이를 것으로 예상됩니다. 시장의 성장은 주로 만성 부비동염의 확장성 증가와 풍선 부비동 성형술과 같은 최소 침습 수술의 경향 증가와 같은 요인에 의해 주도됩니다.
“The Sinus stents/implants is projected to grow at highest CAGR of 8.2% from 2022 to 2027”
Based on the product, the sinus dilation devices market is classified into Balloon sinus dilation devices, Endoscopes (Sinuscopes, Rhinoscopes), Sinus stents/implants, and Handheld instruments. The growth of this market is majorly driven by the factors such as Advantages of balloon dilation procedures compared to traditional endoscopic sinus surgeries and Elevated regularity in chronic sinusitis.
“Asia Pacific is estimated to register the highest CAGR during the forecast period.”
In this report, the sinus dilation devices market is branched into four significant regional segments such as, North America, Europe, Asia Pacific, and the Rest of the World (RoW). The market in Asia Pacific is projected to register the highest growth rate during the forecast period. The growth in this market is primarily driven by the rising geriatric population, increasing per capita income and presence of low cost treatments.
Breakdown of supply-side primary interviews, by company type, designation, and region:
• By Company Type: Tier 1 (32%) , Tier 2 (44%), and Tier 3 (24%)
• By Designation: C-level (30%), Director-level (34%), and Others (36%)
• By Region: North America (40%), Europe (28%), AsiaPacific (20%), and Rest of the World(12%)
List of Companies Profiled in the Report
• Acclarent, inc. (a subsidiary of Johnson & Johnson) (US)
• Olympus Corporation (Japan)
• Entellus Medical Inc. (A Subsidiary of Stryker) (US)
• Medtronic Plc. (Ireland)
• Smith & Nephew plc (UK)
• Intersect ENT, Inc. (US)
• SinuSys Corporation (US)
• InnAccel Pvt. Ltd (India)
• MERIL LIFE SCIENCES PVT Ltd. (India)
• Optim LLC (US)
• EMOS Technology GmbH (Germany)
• KARL STORZ (Germany)
• PENTAX Medical (Japan)
• Sklar Surgical Instruments (US)
• Dalent Medical (US).
• Angiplast Pvt. Ltd. (India)
• Summit Medical LLC. (US)
• Richard Wolf GmbH (Germany)
• Entermed (Germany)
• SCHÖLLY FIBEROPTIC GMBH (Germany)
• XION GmbH (Germany)
• Cook Medical (US)
• Maxer Endoscopy GmbH (Germany)
• ESC Medicams (India)
• Jilin Coronado Medical Ltd. (China)
Research Coverage:
This report studies the sinus dilation devices market based on product, and region. The report also analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total sinus dilation devices market. The report forecasts the revenue of the market segments with respect to four major regions.
Reasons to Buy the Report:
The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on sinus dilation devices offered by the top 25 players in the sinus dilation devices market. The report analyzes the sinus dilation devices market by product, and region.
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various securement devices across key geographic regions.
• Market Diversification: Exhaustive information about untapped geographies, recent developments, and investments in the sinus dilation devices market
• Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the sinus dilation devices market
목차
TABLE OF CONTENTS
1 INTRODUCTION (Page No. – 25)
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 GEOGRAPHIC SCOPE
1.3.2 YEARS CONSIDERED
1.4 CURRENCY
1.5 LIMITATIONS
1.6 MARKET STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. – 30)
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Secondary sources
2.1.2 PRIMARY DATA
FIGURE 2 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
2.1.2.3 Breakdown of primary interviews
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 5 REVENUE SHARE ANALYSIS ILLUSTRATION FOR JOHNSON & JOHNSON
FIGURE 6 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
FIGURE 7 MARKET SIZE ESTIMATION FROM PARENT MARKET
2.2.1 GROWTH FORECAST
FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 9 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 10 DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ANALYSIS
2.5 STUDY ASSUMPTIONS
2.6 RISK ASSESSMENT
TABLE 1 RISK ASSESSMENT
3 EXECUTIVE SUMMARY (Page No. – 44)
FIGURE 11 SINUS DILATION DEVICES MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)
FIGURE 12 ENDOSCOPES MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 13 SINUS DILATION DEVICES MARKET, BY PATIENT TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 14 SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2022 VS. 2027 (USD MILLION)
FIGURE 15 SINUS DILATION DEVICES MARKET, BY PROCEDURE, 2022 VS. 2027 (USD MILLION)
FIGURE 16 GEOGRAPHIC SNAPSHOT OF SINUS DILATION DEVICES MARKET
4 PREMIUM INSIGHTS (Page No. – 48)
4.1 SINUS DILATION DEVICES MARKET OVERVIEW
FIGURE 17 HIGH PREVALENCE OF CHRONIC SINUSITIS TO DRIVE MARKET
4.2 SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2022–2027
FIGURE 18 HOSPITALS AND ASCS SEGMENT TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
4.3 ASIA PACIFIC: SINUS DILATION DEVICES MARKET, BY PRODUCT AND COUNTRY (2022)
FIGURE 19 BALLOON SINUS DILATION DEVICES SEGMENT TO DOMINATE ASIA PACIFIC MARKET IN 2022
4.4 GEOGRAPHIC SNAPSHOT OF SINUS DILATION DEVICES MARKET
FIGURE 20 CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
5 MARKET OVERVIEW (Page No. – 51)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 21 SINUS DILATION DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 High prevalence of chronic sinusitis
5.2.1.2 Benefits of balloon dilation procedures over traditional endoscopic sinus surgeries
5.2.1.3 Growing preference for minimally invasive surgeries
5.2.1.4 Rising healthcare expenditure
FIGURE 22 CURRENT HEALTH EXPENDITURE PER CAPITA
FIGURE 23 CURRENT HEALTH EXPENDITURE (% OF GDP)
5.2.1.5 Increasing availability of reimbursements
5.2.2 RESTRAINTS
5.2.2.1 Risks associated with sinus surgeries
5.2.2.2 Availability of non-surgical treatments for chronic sinusitis
5.2.3 OPPORTUNITIES
5.2.3.1 Growing healthcare market in emerging economies
FIGURE 24 GROWTH IN CURRENT HEALTHCARE EXPENDITURE PER CAPITA IN BRIC COUNTRIES, 2012–2019
5.2.4 CHALLENGES
5.2.4.1 Dearth of skilled otolaryngologists, ENT surgeons, and endoscopists
5.2.4.2 Survival of small players and new entrants
5.3 RANGES/SCENARIOS
FIGURE 25 PESSIMISTIC SCENARIO
FIGURE 26 OPTIMISTIC SCENARIO
FIGURE 27 REALISTIC SCENARIO
5.4 VALUE CHAIN ANALYSIS
FIGURE 28 VALUE CHAIN ANALYSIS: MAJOR VALUE IS ADDED DURING MANUFACTURING AND ASSEMBLY PHASE
5.5 SUPPLY CHAIN ANALYSIS
FIGURE 29 DIRECT DISTRIBUTION—PREFERRED STRATEGY FOR PROMINENT COMPANIES
5.6 TECHNOLOGY ANALYSIS
TABLE 2 BENEFITS OF ENDOSCOPIC PROCEDURE
5.7 PORTER’S FIVE FORCES ANALYSIS
5.7.1 THREAT OF NEW ENTRANTS
5.7.2 INTENSITY OF COMPETITIVE RIVALRY
5.7.3 BARGAINING POWER OF BUYERS
5.7.4 BARGAINING POWER OF SUPPLIERS
5.7.5 THREAT OF SUBSTITUTES
5.8 KEY STAKEHOLDERS AND BUYING CRITERIA
5.8.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 30 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR END USERS
TABLE 3 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS (%)
5.8.2 BUYING CRITERIA
FIGURE 31 KEY BUYING CRITERIA FOR END USERS
TABLE 4 KEY BUYING CRITERIA FOR END USERS
5.9 REGULATORY LANDSCAPE
TABLE 5 REGULATORY AUTHORITIES GOVERNING SINUS DILATION DEVICES MARKET
5.10 PATENT ANALYSIS
5.11 KEY CONFERENCES AND EVENTS
TABLE 6 LIST OF CONFERENCES AND EVENTS, 2022–2023
5.12 PRICING ANALYSIS
TABLE 7 PRICE RANGE FOR SINUS DILATION DEVICES
5.13 TRADE ANALYSIS
TABLE 8 NUMBER OF EXPORTS AND IMPORTS RELATED TO ENDOSCOPY EQUIPMENT
5.14 ECOSYSTEM ANALYSIS
TABLE 9 ROLE IN ECOSYSTEM
FIGURE 32 KEY PLAYERS OPERATING IN SINUS DILATION DEVICES MARKET
5.15 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
6 SINUS DILATION DEVICES MARKET, BY PRODUCT (Page No. – 82)
6.1 INTRODUCTION
TABLE 10 SINUS DILATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
6.2 BALLOON SINUS DILATION DEVICES
6.2.1 INCREASING PREFERENCE FOR MINIMALLY INVASIVE SURGICAL PROCEDURES TO SUPPORT MARKET
TABLE 11 BALLOON SINUS DILATION DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.3 ENDOSCOPES
TABLE 12 ENDOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 13 ENDOSCOPES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.3.1 SINUSCOPES
6.3.1.1 Largest and fastest-growing segment of endoscopes market
TABLE 14 SINUSCOPES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.3.2 RHINOSCOPES
6.3.2.1 Primarily used to examine nasal cavity and passage
TABLE 15 RHINOSCOPES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.4 SINUS STENTS/IMPLANTS
6.4.1 SINUS STENTS/IMPLANTS ARE USED POSTOPERATIVELY FOLLOWING AN ENDOSCOPIC SINUS SURGERY
TABLE 16 SINUS STENTS/IMPLANTS MARKET, BY REGION, 2020–2027 (USD MILLION)
6.5 HANDHELD INSTRUMENTS
6.5.1 HANDHELD INSTRUMENTS ARE WIDELY USED IN ALMOST ALL KINDS OF SURGERIES
TABLE 17 HANDHELD INSTRUMENTS MARKET, BY REGION, 2020–2027 (USD MILLION)
7 SINUS DILATION DEVICES MARKET, BY PROCEDURE (Page No. – 90)
7.1 INTRODUCTION
TABLE 18 SINUS DILATION DEVICES MARKET, BY PROCEDURE, 2020–2027 (USD MILLION)
7.2 STANDALONE SINUS DILATION PROCEDURES
7.2.1 STANDALONE SINUS DILATION PROCEDURES ARE WIDELY USED FOR SINUS DILATION
TABLE 19 STANDALONE SINUS DILATION PROCEDURES MARKET, BY REGION, 2020–2027 (USD MILLION)
7.3 HYBRID SINUS DILATION PROCEDURES
7.3.1 HYBRID SINUS DILATION PROCEDURES ARE MORE INVASIVE IN NATURE COMPARED TO STANDALONE PROCEDURES
TABLE 20 NUMBER OF SINUS PROCEDURES PERFORMED IN ENGLAND BETWEEN 2010 AND 2019
TABLE 21 HYBRID SINUS DILATION PROCEDURES MARKET, BY REGION, 2020–2027 (USD MILLION)
8 SINUS DILATION DEVICES MARKET, BY PATIENT TYPE (Page No. – 94)
8.1 INTRODUCTION
TABLE 22 SINUS DILATION DEVICES MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION)
8.2 ADULT PATIENTS
8.2.1 ADULT PATIENTS DOMINATE MARKET
FIGURE 33 THE PERCENTAGE DISTRIBUTION OF CHRONIC SINUSITIS BY AGE GROUP.
TABLE 23 ADULT SINUS DILATION DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
8.3 PEDIATRIC PATIENTS
8.3.1 HIGH PREVALENCE OF SINUSITIS IN CHILDREN TO DRIVE MARKET
FIGURE 34 TIME OF ONSET OF CRS TO THE FIRST SURGICAL INTERVENTION FOR ENDOSCOPIC SINUS SURGERY PATIENTS.
TABLE 24 PEDIATRIC SINUS DILATION DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
9 SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING (Page No. – 99)
9.1 INTRODUCTION
TABLE 25 SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION)
9.2 HOSPITALS AND AMBULATORY SURGERY CENTERS
9.2.1 LARGEST AND FASTEST-GROWING END USERS OF SINUS DILATION DEVICES
TABLE 26 SINUS DILATION DEVICES MARKET FOR HOSPITALS AND AMBULATORY SURGERY CENTERS, BY REGION, 2020–2027 (USD MILLION)
9.3 ENT CLINICS
9.3.1 FASTER RECOVERY TIME AND COST-EFFECTIVENESS ARE SUPPORTING SEGMENT GROWTH
TABLE 27 SINUS DILATION DEVICES MARKET FOR ENT CLINICS, BY REGION, 2020–2027 (USD MILLION)
10 SINUS DILATION DEVICES MARKET, BY REGION (Page No. – 102)
10.1 INTRODUCTION
TABLE 28 SINUS DILATION DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 35 NORTH AMERICA: SINUS DILATION DEVICES MARKET SNAPSHOT
TABLE 29 NORTH AMERICA: SINUS DILATION DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 30 NORTH AMERICA: SINUS DILATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 31 NORTH AMERICA: SINUS DILATION DEVICES MARKET, BY PROCEDURE, 2020–2027 (USD MILLION)
TABLE 32 NORTH AMERICA: ENDOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 33 NORTH AMERICA: SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION)
TABLE 34 NORTH AMERICA: SINUS DILATION DEVICES MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION)
10.2.1 US
10.2.1.1 Favorable reimbursement scenario for sinus dilation procedures
TABLE 35 US: SINUS DILATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 36 US: SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION)
TABLE 37 US: SINUS DILATION DEVICES MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Rising geriatric population and associated increase in prevalence of CRS to support market growth
TABLE 38 CANADA: SINUS DILATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 39 CANADA: SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION)
TABLE 40 CANADA: SINUS DILATION DEVICES MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION)
10.3 EUROPE
TABLE 41 EUROPE: SINUS DILATION DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 42 EUROPE: SINUS DILATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 43 EUROPE: SINUS DILATION DEVICES MARKET, BY PROCEDURE, 2020–2027 (USD MILLION)
TABLE 44 EUROPE: ENDOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 45 EUROPE: SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION)
TABLE 46 EUROPE: SINUS DILATION DEVICES MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 Rising geriatric population and increasing R&D—key factors driving market
TABLE 47 GERMANY: SINUS DILATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 48 GERMANY: SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION)
TABLE 49 GERMANY: SINUS DILATION DEVICES MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION)
10.3.2 UK
10.3.2.1 Fastest-growing market for sinus dilation devices in Europe
TABLE 50 UK: SINUS DILATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 51 UK: SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION)
TABLE 52 UK: SINUS DILATION DEVICES MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION)
10.3.3 FRANCE
10.3.3.1 High burden of chronic sinusitis to drive market
TABLE 53 FRANCE: SINUS DILATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 54 FRANCE: SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION)
TABLE 55 FRANCE: SINUS DILATION DEVICES MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION)
10.3.4 ITALY
10.3.4.1 Growing geriatric population to support adoption of sinus dilation devices
TABLE 56 ITALY: SINUS DILATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 57 ITALY: SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION)
TABLE 58 ITALY: SINUS DILATION DEVICES MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION)
10.3.5 SPAIN
10.3.5.1 Rising healthcare expenditure to support market for sinus dilation devices
TABLE 59 SPAIN: SINUS DILATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 60 SPAIN: SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION)
TABLE 61 SPAIN: SINUS DILATION DEVICES MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION)
10.3.6 REST OF EUROPE
TABLE 62 REST OF EUROPE: SINUS DILATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 63 REST OF EUROPE: SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION)
TABLE 64 REST OF EUROPE: SINUS DILATION DEVICES MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION)
10.4 ASIA PACIFIC
FIGURE 36 ASIA PACIFIC: SINUS DILATION DEVICES MARKET SNAPSHOT
TABLE 65 ASIA PACIFIC: SINUS DILATION DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 66 ASIA PACIFIC: SINUS DILATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 67 ASIA PACIFIC: SINUS DILATION DEVICES MARKET, BY PROCEDURE, 2020–2027 (USD MILLION)
TABLE 68 ASIA PACIFIC: ENDOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 69 ASIA PACIFIC: SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION)
TABLE 70 ASIA PACIFIC: SINUS DILATION DEVICES MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION)
10.4.1 CHINA
10.4.1.1 Fastest-growing market for sinus dilation devices
TABLE 71 CHINA: SINUS DILATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 72 CHINA: SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION)
TABLE 73 CHINA: SINUS DILATION DEVICES MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION)
10.4.2 JAPAN
10.4.2.1 Large geriatric population to aid market growth
TABLE 74 JAPAN: SINUS DILATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 75 JAPAN: SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION)
TABLE 76 JAPAN: SINUS DILATION DEVICES MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION)
10.4.3 INDIA
10.4.3.1 High prevalence of sinusitis will drive demand for sinus dilation devices
TABLE 77 INDIA: SINUS DILATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 78 INDIA: SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION)
TABLE 79 INDIA: SINUS DILATION DEVICES MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION)
10.4.4 REST OF ASIA PACIFIC
TABLE 80 REST OF ASIA PACIFIC: SINUS DILATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 81 REST OF ASIA PACIFIC: SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION)
TABLE 82 REST OF ASIA PACIFIC: SINUS DILATION DEVICES MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION)
10.5 REST OF THE WORLD
TABLE 83 REST OF THE WORLD: SINUS DILATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 84 REST OF THE WORLD: SINUS DILATION DEVICES MARKET, BY PROCEDURE, 2020–2027 (USD MILLION)
TABLE 85 REST OF THE WORLD: ENDOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 86 REST OF THE WORLD: SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION)
TABLE 87 REST OF THE WORLD: SINUS DILATION DEVICES MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION)
11 COMPETITIVE LANDSCAPE (Page No. – 131)
11.1 OVERVIEW
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
TABLE 88 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN SINUS DILATION DEVICES MARKET
11.3 REVENUE SHARE ANALYSIS
FIGURE 37 REVENUE ANALYSIS OF KEY PLAYERS IN SINUS DILATION DEVICES MARKET
11.4 MARKET SHARE ANALYSIS
TABLE 89 SINUS DILATION DEVICES MARKET: DEGREE OF COMPETITION
11.5 COMPANY EVALUATION QUADRANT
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
FIGURE 38 COMPANY EVALUATION QUADRANT: SINUS DILATION DEVICES MARKET
11.6 COMPANY EVALUATION QUADRANT FOR SMES/STARTUPS
11.6.1 PROGRESSIVE COMPANIES
11.6.2 STARTING BLOCKS
11.6.3 RESPONSIVE COMPANIES
11.6.4 DYNAMIC COMPANIES
FIGURE 39 COMPANY EVALUATION MATRIX FOR SMES/STARTUPS: SINUS DILATION DEVICES MARKET
11.7 COMPANY FOOTPRINT ANALYSIS
TABLE 90 FOOTPRINT OF COMPANIES IN SINUS DILATION DEVICES MARKET
TABLE 91 REGIONAL FOOTPRINT OF COMPANIES
TABLE 92 PRODUCT FOOTPRINT OF COMPANIES
11.8 COMPETITIVE BENCHMARKING
TABLE 93 SINUS DILATION DEVICES MARKET: LIST OF KEY STARTUPS/SMES
11.9 COMPETITIVE SCENARIO
11.9.1 PRODUCT LAUNCHES/APPROVALS
TABLE 94 KEY PRODUCT LAUNCHES
11.9.2 DEALS
TABLE 95 KEY DEALS
11.9.3 OTHER DEVELOPMENTS
TABLE 96 OTHER KEY DEVELOPMENTS
12 COMPANY PROFILES (Page No. – 148)
12.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 ENTELLUS MEDICAL, INC. (SUBSIDIARY OF STRYKER)
TABLE 97 STRYKER: BUSINESS OVERVIEW
FIGURE 40 STRYKER: COMPANY SNAPSHOT (2021)
12.1.2 MEDTRONIC PLC
TABLE 98 MEDTRONIC PLC: BUSINESS OVERVIEW
FIGURE 41 MEDTRONIC PLC: COMPANY SNAPSHOT (2022)
12.1.3 ACCLARENT, INC. (SUBSIDIARY OF JOHNSON & JOHNSON)
TABLE 99 JOHNSON & JOHNSON: BUSINESS OVERVIEW
FIGURE 42 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2021)
12.1.4 SMITH & NEPHEW PLC
TABLE 100 SMITH & NEPHEW PLC: BUSINESS OVERVIEW
FIGURE 43 SMITH & NEPHEW PLC: COMPANY SNAPSHOT (2021)
12.1.5 INTERSECT ENT, INC.
TABLE 101 INTERSECT ENT, INC.: BUSINESS OVERVIEW
FIGURE 44 INTERSECT ENT, INC.: COMPANY SNAPSHOT (2021)
12.1.6 OLYMPUS CORPORATION
TABLE 102 OLYMPUS CORPORATION: BUSINESS OVERVIEW
FIGURE 45 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2022)
12.1.7 SINUSYS CORPORATION
TABLE 103 SINUSYS CORPORATION: BUSINESS OVERVIEW
12.1.8 INNACCEL TECHNOLOGIES PVT LTD.
TABLE 104 INNACCEL TECHNOLOGIES PVT LTD.: BUSINESS OVERVIEW
12.1.9 MERIL LIFE SCIENCES PVT. LTD.
TABLE 105 MERIL LIFE SCIENCES PVT. LTD.: BUSINESS OVERVIEW
12.1.10 OPTIM LLC
TABLE 106 OPTIM LLC: BUSINESS OVERVIEW
12.2 OTHER PLAYERS
12.2.1 JILIN CORONADO MEDICAL LTD.
TABLE 107 JILIN CORONADO MEDICAL LTD.: BUSINESS OVERVIEW
12.2.2 DALENT MEDICAL
TABLE 108 DALENT MEDICAL: BUSINESS OVERVIEW
12.2.3 EMOS TECHNOLOGY GMBH
TABLE 109 EMOS TECHNOLOGY GMBH: BUSINESS OVERVIEW
12.2.4 SKLAR SURGICAL INSTRUMENTS
TABLE 110 SKLAR SURGICAL INSTRUMENTS: BUSINESS OVERVIEW
12.2.5 KARL STORZ
TABLE 111 KARL STORZ: BUSINESS OVERVIEW
12.2.6 PENTAX MEDICAL
TABLE 112 PENTAX MEDICAL: BUSINESS OVERVIEW
12.2.7 ANGIPLAST PVT. LTD.
TABLE 113 ANGIPLAST PVT. LTD.: BUSINESS OVERVIEW
12.2.8 SUMMIT MEDICAL LLC
TABLE 114 SUMMIT MEDICAL LLC: BUSINESS OVERVIEW
12.2.9 RICHARD WOLF GMBH
TABLE 115 RICHARD WOLF GMBH: BUSINESS OVERVIEW
12.2.10 ENTERMED
TABLE 116 ENTERMED: BUSINESS OVERVIEW
12.2.11 SCHÖLLY FIBEROPTIC GMBH
TABLE 117 SCHÖLLY FIBEROPTIC GMBH: BUSINESS OVERVIEW
12.2.12 XION GMBH
TABLE 118 XION GMBH: BUSINESS OVERVIEW
12.2.13 COOK MEDICAL
TABLE 119 COOK MEDICAL: BUSINESS OVERVIEW
12.2.14 MAXER ENDOSCOPY GMBH
TABLE 120 MAXER ENDOSCOPY GMBH: BUSINESS OVERVIEW
12.2.15 ESC MEDICAMS
TABLE 121 ESC MEDICAMS: BUSINESS OVERVIEW
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX (Page No. – 192)
13.1 INDUSTRY INSIGHTS
13.2 DISCUSSION GUIDE
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.4 CUSTOMIZATION OPTIONS
13.5 RELATED REPORTS
13.6 AUTHOR DETAILS
